by Jas Emmerson | Jan 12, 2023 | Scientific Announcements, Uncategorized
#LongCovid is now affecting over 2 million people in the UK, a “mass disabling event” harming health and livelihoods. In the US, where it is reported over 20 million are afflicted with the condition, Long Covid is being described as the “next public health...
by Jas Emmerson | Sep 22, 2022 | Viewpoints
Schools have returned About a month ago, schools returned for the 2022/23 academic year. This will expose many teachers and students to viruses brought home from summer holidays and socialising with family and friends. These viruses include the new Omicron variants of...
by Jas Emmerson | Sep 15, 2022 | Viewpoints
Attomarker has developed a COVID-19 Antibody Immunity test which is fully CE marked and is fully quantitative referenced to the NIST standard human antibody. The test is a fully quantitative immunoassay calibrated against the conserved S2 regions of the spike protein,...
by Jas Emmerson | Sep 14, 2022 | Viewpoints
What is Immunity? Immunity is a complex process with both innate and adaptive immunity. The adaptive arm of the immune system comprises both antibody responses and T cell responses. Most recently, the role of T cells and antibodies has become an important point of...
by Jas Emmerson | Sep 13, 2022 | Viewpoints
The Attomarker COVID-19 Antibody Immunity Test is a fully quantitative immunoassay calibrated against the conserved S2 regions of the spike protein, omicron spike protein, nucleocapsid and receptor binding domain proteins with recombinant antibodies calibrated against...
